Trial intelligence / Profile preview

Phase IV large-scale safety and effectiveness study of quadrivalent split-virion influenza vaccine

CTR20220316Phase 4Active

Sponsor
Hualan Biological Vaccine
Start
Nov 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, double-blind, single-arm trial of influenza vaccine in influenza, sponsored by Hualan Biological Vaccine. Started Nov 2021; status: active.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on CTR20220316.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20220316.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call